(Q35546615)

8 August 2017

1 reference

title

Epidemic obesity and the metabolic syndrome (English)

1 reference

8 August 2017

Epidemic Obesity and the Metabolic Syndrome (English)

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

15 March 2024

0 references

1 reference

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

15 March 2024

author name string

Steven Haffner

1

1 reference

8 August 2017

Heinrich Taegtmeyer

2

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

8 August 2017

30 September 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14517149

15 March 2024

1 reference

8 August 2017

108

1 reference

8 August 2017

1541-1545

1 reference

8 August 2017

13

1 reference

Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete

8 August 2017

2

32

124

1977

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Banting lecture 1988. Role of insulin resistance in human disease

15 March 2024

3

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.

15 March 2024

4

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study

15 March 2024

5

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study

15 March 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

The continuing epidemics of obesity and diabetes in the United States

15 March 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Global and societal implications of the diabetes epidemic

15 March 2024

8

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

15 March 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Cardiovascular morbidity and mortality associated with the metabolic syndrome

15 March 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

15 March 2024

12

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

15 March 2024

13

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

15 March 2024

14

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

15 March 2024

15

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Insulin resistance in essential hypertension

15 March 2024

16

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

15 March 2024

17

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

15 March 2024

18

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

American Journal of Physiology

15 March 2024

19

271

E1067

1996

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

15 March 2024

20

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting

15 March 2024

21

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

15 March 2024

22

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Stimulation of the sympathetic nervous system during sucrose feeding.

15 March 2024

23

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

The Quarterly Journal of Medicine

15 March 2024

24

61

1081

1986

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

The metabolically obese, normal-weight individual revisited.

15 March 2024

25

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Obesity and the risk of heart failure

15 March 2024

26

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Adaptation and maladaptation of the heart in diabetes: Part I: general concepts

15 March 2024

27

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

15 March 2024

28

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Insulin signalling and the regulation of glucose and lipid metabolism

15 March 2024

29

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

15 March 2024

30

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

15 March 2024

32

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes

15 March 2024

34

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

15 March 2024

35

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

15 March 2024

36

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000088845.17586.EC

15 March 2024

Identifiers

1 reference

release_icyqyagwxfenzphwv4xsckvmuq

8 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/icyqyagwxfenzphwv4xsckvmuq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference